Juxue Li

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Low Density Lipoprotein

Reduced Graphene Oxide

Signaling Pathway

Top Venues

Advanced healthcare materials

Advanced pharmaceutical bulletin

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaotang Guo, Jiming Xu, Xiyuan Lu, Xiaoyan Zheng, Xi Chen, Zhenning Sun, Beilei Shen, Hao Tang, Yiman Duan, Zhengwei Zhou, Xu Feng, Yang Chen, Junjie Wang, Jing Pang, Qin Jiang, Bin Huang, Ning Gu, Juxue Li
Chenodeoxycholic Acid-Modified Polyethyleneimine Nano-Composites Deliver Low-Density Lipoprotein Receptor Genes for Lipid-Lowering Therapy by Targeting the Liver. Advanced healthcare materials (2024)
Xiaotang Guo, Jiming Xu, Xiyuan Lu, Xiaoyan Zheng, Xi Chen, Zhenning Sun, Beilei Shen, Hao Tang, Yiman Duan, Zhengwei Zhou, Xu Feng, Yang Chen, Junjie Wang, Jing Pang, Qin Jiang, Bin Huang, Ning Gu, Juxue Li
Chenodeoxycholic Acid-Modified Polyethyleneimine Nano-Composites Deliver Low-Density Lipoprotein Receptor Genes for Lipid-Lowering Therapy by Targeting the Liver. Advanced healthcare materials (2024)
Xi Chen, Xun Qin, Wen Bai, Junsong Ren, Yang Yu, Huiling Nie, Xiumiao Li, Zhangyu Liu, Jiayu Huang, Juxue Li, Jin Yao, Qin Jiang
Kavain Alleviates Choroidal Neovascularization Via Decreasing the Activity of the HIF-1α/VEGF-A/VEGFR2 Signaling Pathway and Inhibiting Inflammation. Advanced pharmaceutical bulletin 14 (2) (2024)
Xi Chen, Xun Qin, Wen Bai, Junsong Ren, Yang Yu, Huiling Nie, Xiumiao Li, Zhangyu Liu, Jiayu Huang, Juxue Li, Jin Yao, Qin Jiang
Kavain Alleviates Choroidal Neovascularization Via Decreasing the Activity of the HIF-1α/VEGF-A/VEGFR2 Signaling Pathway and Inhibiting Inflammation. Advanced pharmaceutical bulletin 14 (2) (2024)
Xiaotang Guo, Jiming Xu, Xiyuan Lu, Xiaoyan Zheng, Xi Chen, Zhenning Sun, Beilei Shen, Hao Tang, Yiman Duan, Zhengwei Zhou, Xu Feng, Yang Chen, Junjie Wang, Jing Pang, Qin Jiang, Bin Huang, Ning Gu, Juxue Li
Chenodeoxycholic Acid-Modified Polyethyleneimine Nano-Composites Deliver Low-Density Lipoprotein Receptor Genes for Lipid-Lowering Therapy by Targeting the Liver. Advanced healthcare materials 13 (22) (2024)